NEUCA Capital Group

NEUCA is a Poland-based public healthcare group whose core business is wholesale distribution of pharmaceuticals to pharmacies, especially independent pharmacies. Beyond distribution, the group operates complementary healthcare businesses including pharmaceutical manufacturing, medical clinics, telemedicine, e-commerce, health insurance support, and clinical research through its Pratia network. NEUCA is also active in contract and own-brand medicines through Synoptis Pharma and related manufacturing entities. In clinical research, the group has expanded internationally through Pratia and its investment in OncoBay, with a focus on running clinical trial services rather than developing its own therapeutic pipeline. Overall, NEUCA is best understood as an integrated healthcare and pharma-services platform rather than a drug-discovery biotech.